The United States is a major market for cell lysis technologies, supported by extensive investments in biotechnology, pharmaceutical research, and molecular diagnostics. The presence of leading life science companies, advanced research institutions, and a strong focus on genomics and proteomics research continues to drive demand for efficient cell lysis solutions. Additionally, growing adoption...